Elemental: The unique devastation of cancer in a pandemic
UC research featured in story about cancer care in the age of the coronavirus
Oncologists say the high-stakes work of treating cancer has become even more precarious during the pandemic. Over the course of 2020, cancer specialists have struggled to understand how to protect their patients, whose immune systems are often compromised by therapies.
“We need to keep treating, even in the face of this,” says Trisha Wise-Draper, MD, PhD, associate professor at the University of Cincinnati, UC Health oncologist and member of the UC Cancer Center. “Cancer never stops.”
In July, Layne Weatherford, PhD, a postdoctoral fellow who works with Wise-Draper, presented preliminary findings suggesting immunotherapy (which activates the immune system against cancer) doesn’t worsen complications for people with cancer infected with COVID-19.
“Our advice keeps changing. I think that’s been the hardest part for patients,” says Wise-Draper. “They’re watching science unfold in front of their eyes.”
Featured photo of cancer cells courtesy of the National Cancer Institute.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.